comparemela.com

Page 5 - Disease Activity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Higher Disease Activity in Early RA Predicts Increased Cardiovascular Disease Risk

Serum-COMP was linked to an increased risk of both cardiovascular disease and coronary artery disease.

Emil rydellResearchgate emil rydellAmerican college of rheumatologyEuropean alliance of associationsUniversity hospital malmSwedish health assessment questionnaireEuropean allianceRheumatology departmentClinical sciencesLund universityDisease activityAmerican college

Patients With RA Receiving DMARDs Have Reduced COVID-19 Vaccine Immune Responses, Study Finds

A cross-sectional study finds that patients with rheumatoid arthritis receiving disease-modifying antirheumatic drugs (DMARDs) exhibit a reduced immune response to the COVID-19 vaccine compared with controls.

Jacob lundDisease activityRheumatoid arthritisCovid 19Disease modifying

Improvements in Ankylosing Spondylitis Patient-Reported Outcomes Linked to Enhanced Work Productivity

Incremental improvements in patient-reported outcomes are linked to enhancements in work productivity and daily life in individuals with AS.

Arthritis care researchArthritis careWork productivityActivity impairmentPatient global assessmentDisease activity

JAK Inhibitors Show Comparable Efficacy for Treatment of Rheumatoid Arthritis

Efficacy was found between baricitinib and tofacitinib for the treatment of RA, though baricitinib was associated with greater pain relief.

Disease activity

Peter C Taylor, PhD: Nipocalimab Shows Promise in Rheumatoid Arthritis Treatment

Peter C Taylor, PhD, discusses the efficacy and safety of nipocalimab in patients with active rheumatoid arthritis.

Peterc taylorNorman collissonUniversity of oxfordMusculoskeletal sciencesDisease activityRheumatoid arthritisCitrullinated protein antigens

vimarsana © 2020. All Rights Reserved.